Reduced acetylcholine receptors and increased acetylcholinesterase activity in AD cause hyperphosphorylation of Tau protein, reduced secretion of soluble amyloid precursor protein (APP) and increased synthesis of Aβ. This evidence concerns the gene APP and Alzheimer disease.